Autogenous cortical bone and bioactive glass grafting for treatment of intraosseous periodontal defects

Mahmut Sumer; Gonca Cayir Keles; Burcu Ozkan Cetinkaya; Umut Balli; Ferda Pamuk; Sina Uckan

doi:10.1055/s-0039-1698989

European Journal of Dentistry, Table of Contents

CC BY-NC-ND 4.0 · Eur J Dent 2013; 07(01): 006-014
DOI: 10.1055/s-0039-1698989

Original Article

Dental Investigation Society

Autogenous cortical bone and bioactive glass grafting for treatment of intraosseous periodontal defects

Authors

Mahmut Sumer

¹Department of Oral Surgery
Gonca Cayir Keles

²Department of Periodontology
Burcu Ozkan Cetinkaya

²Department of Periodontology
Umut Balli

²Department of Periodontology
Ferda Pamuk

³Department of Periodontology
Sina Uckan

⁴Department of Oral Surgery

Abstract

PDF Download

Abstract

Objective: The aim of this 6-month prospective randomized clinical study was to compare the effectiveness of autogenous cortical bone (ACB) and bioactive glass (BG) grafting for the regenerative treatment of intraosseous periodontal defects.

Methods: Via a split-mouth design, 15 chronic periodontitis patients (7 men, 8 women; mean age, 43.47 ± 1.45 years) who had probing pocket depths (PPDs) of ≥6 mm following initial periodontal therapy were randomly assigned to receive 2 treatments in contralateral areas of the dentition: ACB grafting and BG grafting. The parameters compared in the patients were preoperative and 6-month postoperative PPDs, clinical attachment levels (CALs), and radiographic alveolar bone heights.

Results: Both treatment modalities resulted in significant changes in postoperative measurements when compared to preoperative values (p lt; 0.01). PPDs were decreased, CALs were increased, and radiographic alveolar bone heights were increased by 5.00 ± 0.28, 4.60 ± 0.21, and 5.80 ± 0.43 mm in patients treated with ACB grafting and 5.13 ± 0.32, 4.67 ± 0.27, and 5.33 ± 0.36 mm in patients treated with BG grafting, respectively. Differences between the treatments were not statistically significant (P>.05).

Conclusions: Within the limitations of this study, both ACB and BG grafting led to significant improvements in clinical and radiographic parameters 6 months postoperatively. These results suggest that either an ACB graft, which is completely safe with no associated concerns about disease transmission and immunogenic reactions, or a BG graft, which has an unlimited supply, can be selected for regenerative periodontal treatment. (Eur J Dent 2013;7:6-14)

Key words

Bone graft - bioactive glass - periodontal defect - periodontal regeneration

PDF (136 kb)

References

REFERENCES
1 Socransky SS, Haffajee AD. The nature of periodontal disease. Ann Periodontol 1997;2:3-10.
2 Flemmig TF. Periodontitis. Ann Periodontol 1999;4:32-38.
3 Polimeni G, Xiropaidis AV, Wikesjö UM. Biology and principles of periodontal wound healing/regeneration. Periodontol 2000 2006;41:30-47.
4 Caton JG, Greenstein G. Factors related to periodontal regeneration. Periodontol 2000 1993;1:9-15.
5 Carranza FA, Takei HH, Cochran DL. Reconstructive periodontal surgery. In: Newman MG, Takei HH, Klokkevold PR. Carranza FA, eds. Clinical periodontology, vol. 10. St Louis, Missouri, USA: Saunders; 2006:968-990.
6 Brunsvold MA, Mellonig JT. Bone grafts and periodontal regeneration. Periodontol 2000 1993;1:80-91.
7 Kim CS, Choi SH, Cho KS, Chai JK, Wikesjö UM, Kim CK. Periodontal healing in one-wall intra-bony defects in dogs following implantation of autogenous bone or a coral-derived biomaterial. J Clin Periodontol 2005;32:583-589.
8 MacNeill SR, Cobb CM, Rapley JW, Glaros AG, Spencer P. In vivo comparison of synthetic osseous graft materials. A preliminary study. J Clin Periodontol 1999;26:239-245.
9 Deliberador TM, Nagata MJ, Furlaneto FA, Melo LG, Okamoto T, Sundefeld ML, Fucini SE. Autogenous bone graft with or without a calcium sulfate barrier in the treatment of Class II furcation defects: a histologic and histometric study in dogs. J Periodontol 2006;77:780-789.
10 Marx RE. Clinical application of bone biology to mandibular and maxillary reconstruction. Clin Plast Surg 1994;21:377- 392.
11 Chan C, Thompson I, Robinson P, Wilson J, Hench L. Evaluation of Bioglass/dextran composite as a bone graft substitute. Int J Oral Maxillofac Surg 2002;31:73-77.
12 Cancian DC, Hochuli-Vieira E, Marcantonio RA, Garcia Júnior IR. Utilization of autogenous bone, bioactive glasses, and calcium phosphate cement in surgical mandibular bone defects in Cebus apella monkeys. Int J Oral Maxillofac Implants 2004;19:73-79.
13 Ducheyne P. Bioceramics: Material characteristics versus in vivo behavior. J Biomed Mater Res 1987;21:219–236.
14 Froum SJ, Weinberg MA, Tarnow D. Comparison of bioactive glass synthetic bone graft particles and open debridement in the treatment of human periodontal defects. A clinical study. J Periodontol 1998;69:698-709.
15 Keles GC, Cetinkaya BO, Albayrak D, Koprulu H, Acikgoz G. Comparison of platelet pellet and bioactive glass in periodontal regenerative therapy. Acta Odontol Scand 2006;64:327-333.
16 Lovelace TB, Mellonig JT, Meffert RM, Jones AA, Nummikoski PV, Cochran DL. Clinical evaluation of bioactive glass in the treatment of periodontal osseous defects in humans. J Periodontol 1998;69:1027-1035.
17 Wilson J, Low SB. Bioactive ceramics for periodontal treatment: comparative studies in the Patus monkey. J Appl Biomater 1992;3:123-129.
18 Anderegg CR, Alexander DC, Freidman M. A bioactive glass particulate in the treatment of molar furcation invasions. J Periodontol 1999;70:384-387.
19 Wilson J, Pigott GH, Schoen FJ, Hench LL. Toxicology and biocompatibility of bioglasses. J Biomed Mater Res 1981;15:805-817.
20 Williams DF. The biocompatibility and clinical uses of calcium phosphate ceramics. In: Williams DF (ed). Biocompatibility of Tissue Analogs, vol 2. Boca Raton, FL:CRC Press, 1985:44-65.
21 Cancian DCJ, Hochuli-Vieira E, Marcantonio RAC, Marcantonio E Jr. Use of BioGran and Calcitite in bone defects. Histologic study in monkeys (Cebus apella). Int J Oral Maxillofac Implants 1999;14:859-864.
22 Ong MMA. Evaluation of a bioactive glass alloplastic in treating periodontal intrabony defects. J Periodontol 1998;69:1346-1354.
23 Nevins ML, Camelo M, Nevins M, King CJ, Oringer RJ, Schenk RK, Fiorellini JP. Human histologic evaluation of bioactive ceramic in the treatment of periodontal osseous defects. Int J Periodontics Restorative Dent 2000;20:458-467.
24 Sculean A, Windisch P, Keglevich T, Gera I. Clinical and histologic evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans. Int J Periodontics Restorative Dent 2005;25:139-147.
25 Cetinkaya BO, Keles GC, Ayas B, Aydin O, Kirtiloglu T, Acikgoz G. Comparison of the proliferative activity in gingival epithelium after surgical treatments of intrabony defects with bioactive glass and bioabsorbable membrane. Clin Oral Investig 2007;11:61-68.
26 Block MS, Kent JN. Long-term radiographic evaluation of hydroxylapatite-augmented mandibular alveolar ridges. J Oral Maxillofac Surg 1984;42:793-796.
27 Boyne PJ. Transplantation, implantation and grafts. Dent Clin North Am 1971;15: 433-53.
28 Brown KLB, Cruess RL. Bone and cartilage transplantation in orthopedic surgery. J Bone Joint Surg 1982;64:270-279.
29 Marx RE. Philosophy and particulars of autogenous bone grafting. Oral Maxillofac Surg Clin North Am 1993;5:599-605.
30 Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
31 Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21:533-551. 32. Zamet JS, Darbar UR, Griffiths GS, Bulman JS, Brägger U, Bürgin W, Newman HN. Particulate bioglass as a grafting material in the treatment of periodontal intrabony defects. J Clin Periodontol 1997;24:410-418.
33 Grifﬁths GS, Coulthurst SK, Gillett IR, Johnson NW. A ﬁlm and cassette holder for simultaneous xeroradiography and conventional radiography in longitudinal studies. Br Dent J 1988;164:365-367.
34 Von Wowern N, Westergaard J, Kollerup G. Bone mineral content and bone metabolism in young adults with severe periodontitis. J Clin Periodontol 2001;28:583-588.
35 Oates TW, Graves DT, Cochran DL. Clinical, radiographic and biochemical assessment of IL-1/TNF-a antagonist inhibition of bone loss in experimental periodontitis. J Clin Periodontol 2002;29:137-143.
36 Sculean A, Chiantella GC, Windisch P, Arweiler NB, Brecx M, Gera I. Healing of intra-bony defects following treatment with a composite bovine-derived xenograft (Bio-Oss Collagen) in combination with a collagen membrane (Bio-Gide PERIO). J Clin Periodontol 2005;32:720-724.
37 Norton MR, Wilson J. Dental implants placed in extraction sites implanted with bioactive glass: human histology and clinical outcome. Int J Oral Maxillofac Implants. 2002 Mar- Apr;17:249-257.
38 Schepers EJ, Ducheyne P. Bioactive glass particles of narrow size range for the treatment of oral bone defects: a 1-24 month experiment with several materials and particle sizes and size ranges. J Oral Rehabil 1997;24:171-181.
39 Tadjoedin ES, de Lange GL, Holzmann PJ, Kulper L, Burger EH. Histological observations on biopsies harvested following sinus floor elevation using a bioactive glass material of narrow size range. Clin Oral Implants Res. 2000;11:334-44.
40 Lekovic V, Camargo PM, Weinlaender M, Vasilic N, Aleksic Z, Kenney EB. Effectiveness of a combination of plateletrich plasma, bovine porous bone mineral and guided tissue regeneration in the treatment of mandibular grade II molar furcations in humans. J Clin Periodontol 2003;30:746-751.
41 Cortellini P, Carnevale G, Sanz M, Tonetti MS. Treatment of deep and shallow intrabony defects. A multicenter randomized controlled clinical trial. J Clin Periodontol 1998;25:981- 987.
42 Listgarten MA, Rosenberg MM. Histological study of repair following new attachment procedures in human periodontal lesions. J Periodontol 1979;50:333-344.
43 Zybutz M, Rapoport D, Laurell L, Persson GR. Comparisons of clinical and radiographic measurements of inter-proximal vertical defects before and 1 year after surgical treatments. J Clin Periodontol 2000;27:179-186.
44 Keles GC, Sumer M, Cetinkaya BO, Tutkun F, Simsek SB. Effect of autogenous cortical bone grafting in conjunction with guided tissue regeneration in the treatment of intraosseous periodontal defects. Eur J Dent 2010;4:403-411.
45 Shirmohammadi A, Chitsazi MT, Lafzi A. A clinical comparison of autogenous bone graft with and without autogenous periodontal ligament graft in the treatment of periodontal intrabony defects. Clin Oral Investig 2009;13:279-286.
46 Reynolds MA, Aichelmann-Reidy ME, Branch-Mays GL, Gunsolley JC. The efficacy of bone replacement grafts in the treatment of periodontal osseous defects. A systematic review. Ann Periodontol 2003;8:227-265.
47 Park JS, Suh JJ, Choi SH, Moon IS, Cho KS, Kim CK, Chai JK. Effects of pretreatment clinical parameters on bioactive glass implantation in intrabony periodontal defects. J Periodontol 2001;72:730-740.
48 Sanz M, Tonetti MS, Zabalegui I, Sicilia A, Blanco J, Rebelo H, Rasperini G, Merli M, Cortellini P, Suvan JE (2004) Treatment of intrabony defects with enamel matrix proteins or barrier membranes: results from a multicenter practicebased clinical trial. J Periodontol 75:726-733
49 Levin MP, Getter L, Cutright DE. A comparison of iliac marrow and biodegradable ceramic in periodontal defects. J Biomed Mater Res 1975;9:183-195.
50 Trombelli L, Annunziata M, Belardo S, Farina R, Scabbia A, Guida L. Autogenous bone graft in conjunction with enamel matrix derivative in the treatment of deep periodontal intra- osseous defects: a report of 13 consecutively treated patients. J Clin Periodontol 2006;33:69-75.
51 Guida L, Annunziata M, Belardo S, Farina R, Scabbia A, Trombelli L. Effect of autogenous cortical bone particulate in conjunction with enamel matrix derivative in the treatment of periodontal intraosseous defects. J Periodontol 2007;78:231-238.
52 Bauer TW, Muschler GF. Bone graft materials. An overview of the basic science. Clin Orthop Relat Res 2000;371:10-27.
53 Sculean A, Chiantella GC, Windisch P, Gera I, Reich E. Clinical evaluation of an enamel matrix protein derivative (Emdogain) combined with a bovine-derived xenograft (Bio- Oss) for the treatment of intrabony periodontal defects in humans. Int J Periodontics Restorative Dent 2002;22:259-267.
54 Karring T, Lindhe J, Cortellini P. Regenerative periodontal therapy. In: Lindhe J, Karring T, Lang NP, eds. Clinical periodontology and implant dentistry, vol. 4. Oxford, UK: Wiley- Blackwell Publishing Ltd; 2003:650-704.